8-K current report · filed Nov 9, 2026

Zymeworks Inc. (ZYME) 8-K Current Report: November 9, 2026

Item 2.02Item 7.01Item EX-99.1ZYME overview

Short answer

Zymeworks Inc. (ZYME) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results announced for the three months ended September 30, 2026.

Zymeworks Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 financial results announced for the three months ended September 30, 2026
  • Full financial details and management commentary contained in Exhibit 99.1, the attached press release

Item 7.01 · Regulation FD Disclosure

  • Zymeworks identifies SEC filings, press releases, investor websites, conferences and social media as potential sources of material information
  • Investors should monitor these channels for updates on product candidates, corporate developments and other market-sensitive disclosures
  • Regulation FD strategy broadens disclosure distribution beyond formal SEC filings, increasing importance of company communications between filings

Item EX-99.1 · Exhibit EX-99.1

  • 3Q revenue $256.5M vs $27.6M, driven by $250.0M Ziihera approval milestone from Jazz
  • 2026 guidance raised: revenue $337M-$351M and Adjusted EBITDA $176M-$190M
  • Ziihera first-line GEA approval expands royalties and delivered the $250M milestone, with up to $190M additional ex-U.S. milestones
  • Roche ZW209 deal offers $55M upfront, $40M Phase 1b payment, up to $718M milestones, plus tiered royalties pending HSR clearance
  • Theravance acquisition adds YUPELRI revenue and targets $13M-$15M annual overhead savings, but increased leverage and integration costs weigh on financial risk

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Zymeworks Inc. 8-K filings

Get the next ZYME 8-K as it lands

Follow ZYME for push alerts, or ask the research agent what this filing means.